XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)
 9 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Beginning balance $ 2,545,565 $ 995,760
Acquisition of Biowin 15,322
Charge to expense 2,401,297 2,117,316
Less: cessation of subsidiaries and disposal of VIE (326,491)
Foreign currency translation adjustments (430,001) (241,020)
Ending balance $ 4,532,183 $ 2,545,565